While the safety measures taken at the beginning of the pandemic saved lives, a full accounting of COVID-19's impact must include the economic, social, and health effects of pandemic response strategies
Link found between state governors political parties and COVID-19 case and death rates jhu.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jhu.edu Daily Mail and Mail on Sunday newspapers.
Study suggests immunosuppressive drugs do not contribute to severity of COVID-19
Findings contribute to a growing body of evidence that may provide reassurance to clinicians and patients using chronic immunosuppressive medications By Bloomberg School of Public Health staff report / Published Jan 13, 2021
People taking immunosuppressive drugs to prevent organ transplant rejection or to treat inflammatory or autoimmune diseases do not fare worse than others on average when they are hospitalized with COVID-19, according to a new study from researchers at the Johns Hopkins Bloomberg School of Public Health.
Estimates suggest that there are approximately 10 million immunocompromised people in the U.S. alone. Suppression of the immune system has been considered a potentially major risk factor for severe and fatal COVID-19 because it could allow the SARS-CoV-2 virus to spread unchecked in the body. At the same time, there have been anecdotal
(410) 614-6029
The Johns Hopkins Bloomberg School of Public Health, with the Johns Hopkins schools of Nursing and Medicine and in partnership with the Baltimore City Health Department, is launching two free online educational courses for administrators, owners, and managers of assisted living and senior housing communities to help prepare for and respond to COVID-19. During the next phases of the pandemic, including the current surge and the impending vaccine rollout, assisted living and senior housing communities serving high-risk populations continue to be on the frontlines of COVID-19 emergency response.
The self-paced, web-based courses, made available on Coursera.org, are the latest in a series from the Johns Hopkins University COVID-19 Training Initiative and part of its COVID-19 Resources for Practitioners. This initiative, launched in May with a contact tracing course that has seen more than 1 million enrollments, offers expertise and practical guidance from the top-ranked